A hepatitis C avidity test for determining recent and past infections in both plasma and dried blood spots

Journal of Clinical Virology

Volumn 57, Issue 1, 2013, Pages 29-35

  Shepherd, Samantha J ^a   Kean, Joy ^a   Hutchinson, Sharon J ^b,c   Cameron, Sheila O ^a   Goldberg, David J ^b   Carman, William F ^a   Gunson, Rory N ^a   Aitken, Celia ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Avidity; Chronic; DBS; HCV; Recent; Resolved

Indexed keywords

UREA;

ADOLESCENT; ADULT; AGED; ALGORITHM; ANTIBODY DETECTION; ARTICLE; BINDING AFFINITY; CHILD; DIAGNOSTIC PROCEDURE; DISEASE CARRIER; DISEASE SURVEILLANCE; DRIED BLOOD SPOT TESTING; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL MONITORING; FALSE POSITIVE RESULT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; PLASMA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROCONVERSION;

ADOLESCENT; ADULT; AGED; ANTIBODY AFFINITY; CHILD; CHILD, PRESCHOOL; DRIED BLOOD SPOT TESTING; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; LIMIT OF DETECTION; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84875812852     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.01.002     Document Type: Article

References (28)

1. Hepatitis C in the UK 2012, HPA, London.
2. Croom H.A., Richards K.M., Best S.J., Francis B.H., Johnson E.I.M., Dax E.M., et al. Commercial enzyme immunoassay adapted for the detection of antibodies to hepatitis C virus in dried blood spots. J Clin Virol 2006, 36(1):68-71.
3. Tuaillon E., Mondain A.M., Meroueh F., Ottomani L., Picot M.C., Nagot N., et al. Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology 2010, 51(3):752-758.
4. Judd A., Parry J., Hickman M., McDonald T., Jordan L., Lewis K., et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003, 71(1):49-55.
5. Hickman M., McDonald T., Judd A., Nichols T., Hope V., Skidmore S., et al. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomised controlled trial. J Viral Hepat 2008, 15(4):250-254.
6. Hope V.D., Hickman M., Ngui S.L., Jones S., Telfer M., Bizzarri M., et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat 2011, 18(4):262-270.
7. Allen E.J., Palmateer N.E., Hutchinson S.J., Cameron S., Goldberg D.J., Taylor A. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. Int J Drug Policy 2012, 23(5):346-352.
8. Dore G.J., Hellard M., Matthews G.V., Grebely J., Haber P.S., Petoumenos K., et al. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology 2010, 138(1):123-135.
9. Grebely J., Matthews G.V., Hellard M., Shaw D., van Beek I., Petoumenos K., et al. Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. J Hepatol 2011, 55(1):76-85.
10. EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol 2011, 55(2):245-264.
11. Ghany M.G., Strader D.B., Thomas D.L., Seeff L.B. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49(4):1335-1374.
12. Sagnelli E., Coppola N., Marrocco C., Coviello G., Battaglia M., Messina V., et al. Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. J Hepatol 2005, 42(5):646-651.
13. Dimitrov J.D., Lacroix-Desmazes S., Kaveri S.V. Important parameters for evaluation of antibody avidity by immunosorbent assay. Anal Biochem 2011, 418(1):149-151.
14. Inouye S., Hasegawa A., Matsuno S., Katow S. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol 1984, 20(3):525-529.
15. Ward K.N., Dhaliwal W., Ashworth K.L., Clutterbuck E.J., Teo C.G. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J Med Virol 1994, 43(4):367-372.
16. Kanno A., Kazuyama Y. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection. J Med Virol 2002, 68(2):229-233.
17. Coppola N., Pisapia R., Marrocco C., Martini S., Vatiero L.M., Messina V., et al. Anti-HCV IgG avidity index in acute hepatitis C. J Clin Virol 2007, 40(2):110-115.
18. Klimashevskaya S., Obriadina A., Ulanova T., Bochkova G., Burkov A., Araujo A., et al. Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index. J Clin Microbiol 2007, 45(10):3400-3403.
19. Gaudy-Graffin C., Lesage G., Kousignian I., Laperche S., Girault A., Dubois F., et al. Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection. J Clin Microbiol 2010, 48(9):3281-3287.
20. Daniel H.D., Grant P.R., Garson J.A., Tedder R.S., Chandy G.M., Abraham P. Quantitation of hepatitis C virus using an in house real time reverse transcriptase polymerase chain reaction plasma samples. Diagn Microbiol Infect Dis 2008, 61(4):415-420.
21. Bennett S., Gunson R.N., McAllister G.E., Hutchinson S., Goldberg D.J., Cameron S., et al. Detection of hepatitis C virus RNA in dried blood spots. J Clin Virol 2012, 54(2):106-109.
22. Revello M.G., Genini E., Gorini G., Klersy C., Piralla A., Gerna G. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J Clin Virol 2010, 48(4):255-259.
23. Coppola N., Pisapia R., Tonziello G., Masiello A., Martini S., Pisaturo M., et al. Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG avidity index. J Clin Virol 2009, 46(3):222-229.
24. Thomson E.C., Nastouli E., Main J., Karayiannis P., Eliahoo J., Muir D., McClure M.O. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009, 23(1):89-93.
25. Lefevre-Pettazzoni M., Bissery A., Wallon M., Cozon G., Peyron F., Rabilloud M. Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women. Clin Vaccine Immunol 2007, 14(3):239-243.
26. Re M.C., Schiavone P., Bon I., Vitone F., De Crignis E., Biagetti C., et al. Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy. Int J Infect Dis 2010, 14(11):e1008-e1012.
27. Araujo A.C., Astrakhantseva I.V., Fields H.A., Kamili S. Distinguishing acute from chronic hepatitis C virus (HCV) infection based on antibody reactivities to specific HCV structural and non-structural proteins. J Clin Microbiol 2011, 49(1):54-57.
28. Murphy G. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 2008, 13(7-9):4-10.